2. Go UY, Park MS, Kim UN, Lee SD, Han SM, Lee JS, Yang JY, Kim JE, Park SY, Kim YM, Yoo HS, Cha JO, Park WS, Kang HY, Kim H, Park GR, Kim MJ, Park O, Son HJ, Cho EH, Na KI, Kwon YH, Lee YK, Lee KH, Jeong EK, Lee DH, Yang BG, Jeon BY, Lee JK. Korea Tuberculosis Epidemic Investigation Service. Tuberculosis prevention and care in Korea: evolution of policy and practice. J Clin Tuberc Other Mycobact Dis 2018;11:28-36.
4. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-1158.
5. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49((RR-6):1-51.
6. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54((RR-17):1-141.
7. Joint Committee for the Revision of Korean Guidelines for Tuberculosis. Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 3rd ed. Cheongju: Korea Centers for Disease Control and Prevention; 2017.
10. Lee JE, Kim YK, Kim TH, Kim KH, Lee EJ, Uh ST, Choi TY. What strategy can be applied to the patients with culture positive tuberculosis to reduce treatment delay in a private tertiary healthcare center? Infect Chemother 2011;43:42-47.